We’re seeking a laboratory partner capable of providing high-volume urine drug abuse screening, with a smaller percentage of specimens requiring confirmatory testing. The laboratory should have the capacity to support, or scale to support, national testing volumes. The associated testing product is currently US FDA- and UK MDA-approved and has recently been upgraded with a patent pending with the USPTO.
Target Completion DateAugust 30, 2026
Length of ServiceRecurring service indefinitely
Can you help?